DASATINIB
These highlights do not include all the information needed to use DASATINIB TABLETS safely and effectively. See full prescribing information for DASATINIB TABLETS. DASATINIB tablets, for oral use Initial U.S. Approval: 2006
58ce42c6-10bd-4bb4-bf89-eae8ed82c339
HUMAN PRESCRIPTION DRUG LABEL
Aug 3, 2024
Aurobindo Pharma Limited
DUNS: 650082092
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
DASATINIB
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
DASATINIB
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
DASATINIB
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
DASATINIB
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
DASATINIB
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
DASATINIB
Product Details
FDA regulatory identification and product classification information
